Your browser doesn't support javascript.
loading
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors.
Hu, Jiemiao; Yang, Qing; Zhang, Wendong; Du, Hongwei; Chen, Yuhui; Zhao, Qingnan; Dao, Long; Xia, Xueqing; Natalie Wall, Fowlkes; Zhang, Zhongting; Mahadeo, Kris; Gorlick, Richard; Kopetz, S; Dotti, Gianpietro; Li, Shulin.
Afiliação
  • Hu J; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yang Q; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang W; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Du H; Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Chen Y; Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Zhao Q; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dao L; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Xia X; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Natalie Wall F; Veterinary Medicine & Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang Z; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mahadeo K; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dotti G; Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Li S; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
J Immunother Cancer ; 10(1)2022 01.
Article em En | MEDLINE | ID: mdl-35027427
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Interleucina-12 / Terapia Baseada em Transplante de Células e Tecidos / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Interleucina-12 / Terapia Baseada em Transplante de Células e Tecidos / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article